DBV Technologies ADR (NASDAQ: DBVT) kicked off on Monday, down -10.81% from the previous trading day, before settling in for the closing price of $19.05. Over the past 52 weeks, DBVT has traded in a range of $3.30-$26.18.
Annual sales at Healthcare sector company grew by 24.08% over the past five years. While this was happening, its average annual earnings per share was recorded -60.77%. With a float of $32.94 million, this company’s outstanding shares have now reached $40.14 million.
DBV Technologies ADR (DBVT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of DBV Technologies ADR is 17.94%, while institutional ownership is 33.81%. The most recent insider transaction that took place on Dec 17 ’25, was worth 10,070,232. In this transaction Member of 10% owner group of this company sold 2,076,990 shares at a rate of $4.85, taking the stock ownership to the 8,595,472 shares. Before that another transaction happened on Dec 18 ’25, when Company’s Member of 10% owner group sold 1,292,103 for $4.19, making the entire transaction worth $5,413,912. This insider now owns 7,303,369 shares in total.
DBV Technologies ADR (DBVT) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.21 earnings per share (EPS), higher than consensus estimate (set at -0.21) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -60.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.85% during the next five years compared to 24.08% growth over the previous five years of trading.
DBV Technologies ADR (NASDAQ: DBVT) Trading Performance Indicators
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.24, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of DBV Technologies ADR (DBVT)
DBV Technologies ADR (NASDAQ: DBVT) saw its 5-day average volume 0.37 million, a negative change from its year-to-date volume of 0.44 million. As of the previous 9 days, the stock’s Stochastic %D was 11.51%.
During the past 100 days, DBV Technologies ADR’s (DBVT) raw stochastic average was set at 47.41%, which indicates a significant increase from 2.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.44 in the past 14 days, which was higher than the 0.99 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.94, while its 200-day Moving Average is $11.23. Nevertheless, the first resistance level for the watch stands at $18.39 in the near term. At $19.79, the stock is likely to face the second major resistance level. The third major resistance level sits at $20.60. If the price goes on to break the first support level at $16.18, it is likely to go to the next support level at $15.37. The third support level lies at $13.97 if the price breaches the second support level.
DBV Technologies ADR (NASDAQ: DBVT) Key Stats
The company with the Market Capitalisation of 681.98 million has total of 40,156K Shares Outstanding. Its annual sales at the moment are 4,150 K in contrast with the sum of -113,920 K annual income. Company’s last quarter sales were recorded 2,770 K and last quarter income was -33,160 K.
